Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
A prospective cohort study of vitamin D in optic neuritis recovery.
Teriflunomide for oral therapy in multiple sclerosis.
From genes to characteristics of multiple sclerosis.
Evoked potential tests in clinical diagnosis.
A case of Guillain-Barré syndrome with meningeal irritation.
Drug therapy for multiple sclerosis.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
The visual pathway as a model to understand brain damage in multiple sclerosis.
Defining the new end point for multiple sclerosis treatment.
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo.
The immunogenetics of multiple sclerosis: A comprehensive review.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
Efficacy and safety of FTY720 in patients with relapsing multiple sclerosis
Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise.
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist.
Downbeat nystagmus associated with damage to the medial longitudinal fasciculus of the pons: A vestibular balance control mechanism via the lower brainstem paramedian tract neurons.
A novel method for calculating prevalence of multiple sclerosis in Australia.
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
Enhanced Neuroprotective Effects of Combination Therapy with Bone Marrow-Derived Mesenchymal Stem Cells and Ginkgo biloba Extract (EGb761) in a Rat Model of Experimental Autoimmune Encephalomyelitis.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.

Pages